Pharmacological Effects of Crushing Prasugrel in STEMI Patients
NCT02212028
·
clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
52
Enrollment
OTHER
Sponsor class
Conditions
Coronary Artery Disease
Interventions
DRUG:
prasugrel
Sponsor
University of Florida